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Metal−organic frameworks (MOFs) have risen toprominence as organic−inorganic hybrid materials
with porous structures.1 MOFs externally modiﬁed using
diﬀerent functionalities have emerged as the basis for a new
breed of functional material that oﬀers an array of applications
in drug delivery, sensing, biocatalysts, and cell imaging.2,3 Of
course, if they are loaded with therapeutic molecules, MOFs
have been shown to be capable of eﬃcient drug delivery.4,5 This
means that the possibility of combining functional MOFs with
the carrying of payloads suggests a general synthetic strategy by
which to prepare antibody-functionalized materials to achieve
both targeted cell capture and drug delivery.
Tumor cell analysis plays a vitally important role in cancer
diagnosis, drug screening, and clinical therapeutics.6,7 Circulat-
ing tumor cells (CTCs) are capable of initiating cancer
metastasis by migrating through the vascular system,8 with
the potential to reﬂect the molecular proﬁle and developmental
stage of the primary tumor they escaped.9 This renders their
analysis vital to understanding both the mechanism of tumor
metastasis and oﬀering a prognosis of the primary cancer.
However, the rarity of CTCs makes their detection and analysis
a signiﬁcant challenge; typically only hundreds of CTCs coexist
with 109 hematologic cells.10 It has also been shown that CTCs
are signiﬁcantly heterogeneous, complicating recognition.11
The necessity of capturing CTCs selectively and eﬃciently has
led to the development of a variety of functional materials and
devices.12,13 However, for applications in anticancer drug
screening, it is necessary to fabricate multifunctional platforms
that combine CTC recognition and capture with controlled
drug release.
Here, we successfully fabricate a platform for selective CTC
sequestering that also has the potential for targeted drug
delivery and screening using a composite chip with integrated
dual functionality. Zn-based MOFs (ZnMOFs) have exhibited
diverse practicality with applications reported in the ﬁelds of
sensing,14 imaging,14 and catalysis.15 The fabrication of a rare
example of a ZnMOF bearing free carboxylic acid groups
(ZnMOF-COOH) oﬀers a ﬂexible and scalable platform for the
creation of peptide linkages. This in turn oﬀers a general
method to conjugate large molecules, such as enzymes and
antibodies, to the MOF and provides a simple route to a highly
eﬀective immunotrapper. Hence, the free acid groups borne by
the MOF have undergone postsynthetic modiﬁcation (PSM) to
express antiepithelial cell adhesion molecule (anti-EpCAM)
antibody (see Supporting Information). EpCAM itself is a
transmembrane glycoprotein expressed exclusively in epithelia
and epithelial-derived neoplasms. The up-regulation of EpCAM
(100−1000-fold) relates to cancer progression in virtually all
epithelial carcinomas, making it a promising candidate for
immunotrapping strategies.16 The synthetic strategy by which
PSM gives an immunotrapper functionalized by anti-EpCAM is
summarized in Scheme 1.
In this work, immunotrapper development involved
fabricating a ZnO substrate via high-temperature sintering, on
which was grown a Zn-based MOF (see Supporting
Information for full details of immunotrapper preparation and
characterization). Scanning electron microscopy (SEM) of the
ZnO substrate revealed a nanostructured morphology
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Scheme 1. Schematic Illustrating the Synthetic Strategy for
Fabricating a MOF-Based Immunotrapper
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(Supporting Information Figure S1). Nano-ZnO substrate was
next added to a Teﬂon lined stainless-steel autoclave together
with Zn(NO3)2·6H2O, 1,1′:2′,1″-terphenyl-4,4′,4″,5′-tetracar-
boxylic acid (H4ttca) and 4,4′-bipyridine before being heated to
160 °C for 120 h. X-ray diﬀraction suggested the resulting
material to be a composite in which nano-ZnO was coated by
ZnMOF-COOH (Figure S2).17 The latter was characterized by
N2 gas sorption at 77 K (Figure S3), revealing a surface area of
22.9 m2/g and a pore diameter of 158.2 Å. These data are as
expected.17 The successful synthesis of ZnMOF-COOH,
including the presence of uncoordinated carboxylic groups,
was further conﬁrmed by Fourier transform infrared (FTIR)
spectroscopy (Figure S4).18
Remarkably little work has been done on derivatizing MOFs
that bear free acid groups. An organic amine catalyst has been
hosted by a MOF through acid-base interactions19 while simple
esteriﬁcation has recently been reported.20 However, we
reasoned that PSM should enable the creation of peptide
linkages on MOFs in a way that promises the wide-ranging
ability to covalently immobilize biomacromolecules.21,22 This
would represent a signiﬁcant step, with extant research pointing
to the covalent immobilization of antibodies oﬀering signiﬁcant
advantages over their passive adsorption on substrates. Beneﬁts
would include enhanced stability, dispersibility in the aqueous
phase, control of antibody surface density, improved structure
retention, and reduced blocking of the antigen binding
site.21,23,24 Furthermore, immobilization of enzymes on solid
supports can enhance stability and proteolysis eﬃciency, as well
as ease of separation and recovery for reuse.25 In this work, we
validate our thesis by modifying the surface acid groups on
ZnMOF-COOH, thus conjugating the biotin-sequestering
protein streptavidin (SA) to the ZnMOF-COOH via
incubation in the presence of the activators N-hydroxysulfo-
succinimide (sulfo-NHS) and N-(3-(dimethylamino)propyl)-
N-ethylcarbodiimide hydrochloride (EDC)26 (see also Support-
ing Information Section 2c). SA modiﬁed with Cy3 was
employed to enable the simple veriﬁcation of SA conjugation.
After washing the product with phosphate-buﬀered saline
(PBS), the ﬂuorescence microscopy of SA-Cy3-modiﬁed
ZnMOF-COOH was obtained under laser irradiation at 543
nm (Figure S5). It was clear that the immobilization of SA-Cy3
on the composite surface had been successful.
It proved possible to manipulate ZnMOF-COOH composite
growth by modulating hydrothermal reaction time. After 24 h
of heating, spherical particles (∼5 μm in diameter) were
generated (Figure 1a). However, extending reaction time gave
larger particles with roughened surfaces (Figure 1b−d). Finally,
a reaction time of 120 h led to the generation of spherical
particles (∼150 μm in diameter) coated with spine-like
structures (Figure 1e,f). It is established that the stiﬀness,
charge, and superhydrophilicity26 as well as topology, rough-
ness, and three-dimensional structure27 of a material inﬂuence
its capacity for intercellular interaction and cell capture. In our
case, detailed information was obtained by transmission
electron microscopy (TEM, Figure S6). Results suggested the
alignment of small needles (ca. 20 nm diameter) to form
nanostructured agglomerates. The formation of these is
consistent with the observation by SEM that ZnMOF-COOH
displays a spine-like microstructure.
The grafting of biotinylated anti-EpCAM onto the composite
following its modiﬁcation with SA provides a multistep pathway
to an immunotrapper capable of sequestering speciﬁc types of
tumor cells. This work used MCF-7 as a model cell line (see
Supporting Information Section 3). Hence, a 1 mL MCF-7
suspension (∼104 cells/mL) was incubated with the immuno-
trapper at 37 °C for 45 min in a CO2 incubator. Environmental
scanning electron microscopy (ESEM) showed that MCF-7
cells were successfully captured, with the spines expressed by
ZnMOF-COOH after PSM providing sites for cell sequestering
(Figure 2b−d). To probe MCF-7 capture eﬃciency as a
function of time, cells (100 cells/mL) were incubated with the
trapping platform for 15−60 min (experiments were triplicated,
n = 3). Figure 2e reveals that capture eﬃciency increased from
64% ± 11% at 15 min to 89% ± 7% at 30 min, only slightly
increasing thereafter. As a result, 45 min was chosen as optimal
incubation time, with capture eﬃciency of 91% ± 5% achieved.
The composite ZnMOF-COOH (without antibody conjuga-
tion) was monitored as a control. Incubation for 45 min
revealed 96% ± 1% MCF-7 cells remaining uncaptured (Figure
2e, 45 min*), demonstrating a key role for anti-EpCAM in cell
recognition and capture.
Capture eﬃciency was studied as a function of immuno-
trapper morphology by conducting 45 min incubations using
capture systems in which the ZnMOF-COOH components
were fabricated over 24−120 h (Figure 2f, n = 3). Data revealed
the morphology of the ZnMOF particles has a signiﬁcant eﬀect
on capture eﬃciency. The relatively smooth, spherical particles
produced after 24 h showed unsatisfactory capture eﬃciency
(ca. 50%). However, this rose to >90% for the larger, less
smooth particles that resulted from the 120 h synthesis. This
indicated that, in accordance with previous results,26 a rougher
biointerface beneﬁts interaction of the targeted cells with the
immunotrapper.
The low abundance of CTCs in the bloodstream made it
desirable to test immunotrapper eﬃciency as a function of CTC
concentration, with the levels tested varying from 10 cells to
100 cells/mL in PBS. Figure 2g (n = 3) reveals that after
Figure 1. SEM images of ZnMOF-COOH growing on ZnO substrate.
Hydrothermal reaction times: (a) 24 h, (b) 48 h, (c) 72 h, (d) 96 h,
and (e, f) 120 h. Scale bars: (a) 5 μm, (b) 10 μm, (c) 15 μm, (d) 20
μm, (e) 40 μm, and (f) 15 μm.
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incubation for 45 min, capture eﬃciencies decreased from 91%
± 5% in 1 mL suspensions of 100 CTCs/mL to slightly lower
than 50% for 10 CTCs/mL. Our immunotrapper system was
designed to target EpCAM-positive tumor cells. Diﬀerent
EpCAM-positive and EpCAM-negative cell lines were therefore
used to verify discrimination. Human breast cancer cells (MCF-
7) and human prostate cancer cells (PC3) are EpCAM-positive,
whereas human cervical cancer cells (HeLa) and Daudi
lymphoma cells are EpCAM-negative. Figure 2h (n = 3)
reveals a capture eﬃciency of PC-3 cells similar to that of MCF-
7 cells, reaching 85% ± 8%. In contrast, the ﬁgures for HeLa
and Daudi cells were only ∼5%. Overall, data in Figure 2
establish that the ZnMOF-based platform exhibits both
excellent and targeted recognition of EpCAM-positive tumor
cells.
To further elucidate cell adhesion on the surface of the
ZnMOF-based immunotrapper, immunoﬂuorescence analysis
was undertaken. Representative laser confocal ﬂuorescence
microscopy images are shown in Figure 3 and Supporting
Information Figure S7. MCF-7 cells were stained for the nuclei
and actin ﬁlaments with 4′,6-diamidino-2-phenylindole dihy-
drochloride (DAPI, blue) and goat antirabbit IgG H&L (Alexa
Fluor 647) (red), respectively. Finally, the ﬂuorescence images
were merged with the corresponding bright ﬁeld image of the
immunotrapper. Figure 3 shows the distribution of actin
cytoskeleton, a critically signiﬁcant component in the
interaction of tumor cells and immunotrapping material.28,29
The ESEM images shown in Figure 2b−d (see also Supporting
Information Figure S8) as well as immunoﬂuorescence analyses
shown in Figures 3c and S7 all suggest the tumor cells show an
aﬃnity for regions in which the immunotrapper expresses a
spine-like morphology. Taken together, these data suggest that
in contrast to the core of the composite, which was formed in
the early phase of the hydrothermal synthesis, the spine-like
microstructures formed over longer timeframes provide sites at
which cell adhesion is preferred and which, combined with the
action of anti-EpCAM, enhance selective CTC capture
eﬃciency.
Various functional materials have been developed for
capturing tumor cells. While some have focused on optimal
capture eﬃciency,26,27,30 others have focused on enhanced cell
release after capture.29,31 However, while capture eﬃciencies
greater than those we report have been recorded,26,32 there are,
so far as we are aware, no reports of a multifunctional material
capable of marrying eﬃcient cell capture to drug delivery and
controlled release. In light of this, we considered that beyond
acting merely as a scaﬀold for a cell capture device, ZnMOF-
COOH could be deployed to host and release a therapeutic
cargo in response to an external stimulus.19,33 Doxorubicin
(Dox)4 was chosen as a model drug to test this idea (for
detailed loading/release protocols see Supporting Information).
Data in Figure S9 show that ZnMOF-COOH can load Dox
easily at pH 7.4, reaching adsorption equilibrium (ca. 45%) in
only ca. 5 min. The loaded MOF showed pH-sensitive Dox
release in weakly acidic environments as shown in Figure S10.
After incubation for 1 h in acid buﬀers (pH 4.4−5.6), Dox
desorption reached 50−55%.
As a precursor to future bioapplications development, the
cytotoxicity of the ZnMOF-COOH-based platform has been
investigated. Live/Dead staining (Figure S11) showed 95% ±
1% cells to be viable after incubation for 45 min, with
statistically unchanged viability noted after 5 h of incubation.
This compared with the viability of control groups remaining at
ca. 96% over 5 h. Finally, cell viability in the presence of the
platform decreased to 90% ± 2% after incubation for 24 h.
These data indicated that CTC sequestering experiments
should last <24 h and that the current protocol for testing
capture eﬃciency (see above, Figure 2e) operates on a time
scale on which any cytotoxic eﬀects of the platform manifest
themselves negligibly.
Figure 2. ESEM images of MCF-7 cells captured by a ZnMOF-based
platform. (a) Overall morphology of ZnMOF-COOH after PSM; (b−
d) captured MCF-7 cells. Scale bars: (a) 200 μm, (b) 50 μm, (c) 20
μm, (d) 5 μm. Immunotrapper capture eﬃciency (mean ± SD, n = 3)
as a function of (e) incubation time (45 min* = 45 min incubation
using ZnMOF-COOH without anti-EpCAM conjugation), (f) hydro-
thermal preparation time of ZnMOF-COOH (24−120 h), (g) CTC
concentration, and (h) cell line.
Figure 3. Immunoﬂuorescent staining images showing captured MCF-
7 cells (100 cells/mL, 45 min). (a) Nuclei (DAPI, blue); (b) actin
cytoskeletons (red); (c) composite image based on merged
ﬂuorescence images and bright ﬁeld image of ZnMOF-based
immunotrapper. Scale bars: 50 μm.
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In conclusion, a functional MOF-based platform modiﬁed
with antibodies has been developed to achieve cell recognition
and targeted capture. ZnMOF-COOH assembled in situ on the
surface of a ZnO substrate forms a convenient platform for
further functionalization. This method oﬀers a universal
strategy for the immobilization of antibodies on MOFs by
utilizing the straightforward derivatization of surface acid
groups to give peptide linkages. The resulting ZnMOF-based
platform acted as an eﬃcient trapper of targeted tumor cells,
exhibiting excellent capture capability and selectivity. Crucially,
however, its structural properties also rendered the MOF
capable of delivering drug cargoes and controllably releasing
them in response to external stimuli.33 Overall, the develop-
ment of a MOF-based immunotrapper system that successfully
combines the ﬁelds of targeted cell sequestration with
controllable drug delivery has enormous potential in person-
alized therapy development.
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